Final Exam Flashcards

1
Q

Levothyroxine (Synthroid, Levoxyl)

A

Given for the treatment of hypothyroidism -Synthetic T4; Identical to naturally occurring thyroid hormone

-Converted to T3

Pharmacokinetics

  • Given PO & well absorbed in empty stomach (30-60 min. prior to breakfast) EMPTY STOMACH needed*
  • IV form available
  • Highly protein bound
  • Once per day dosing
  • Takes about 1 month to reach plateau

-Since thyroid hormone occurs naturally in the body, almost anyone can take levothyroxine.
ο Pregnancy Category A (SAFE in pregnancy). The drug does pass in breast milk but is considered safe to use.
Adverse Effects
-Thyrotoxicosis- too much T3 and T4 (thyroid storm)
-Osteoporosis
-Atrial fibrillation

Absorption decreased by:

  • Calcium supplements
  • Antacids
  • ron
  • Cholesterol binding agents
  • Food – esp. important to avoid infant soy formula, cotton seed meal, walnuts and high fiber foods (decreases absorption)

Drugs that accelerate metabolism of levothyroxine:

  • Phenytoin, carbamazepine, rifampin
  • Warfarin
  • Levothyroxine accelerates the degradation of vit K dependent clotting factors
  • There increased effects of warfarin
  • Catecholamines
  • Thryroid hormones increase the responsiveness to catecholamines…use cautiously
  • Epinephrine, dopamine, dobutamine
  • Insulin and digoxin

Levothyroxine can increase the requirements for both of these drugs

Nursing Implications:

  • Monitor height and development in infants and children
  • Teach to take on empty stomach
  • Frequent follow up and lab monitoring
  • Different brands of levothyroxine may NOT work the same
  • Blood work after 6 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Methimazole (Tapazole)

A

Treatment for Hyperthyroidism
First line drug

MOA:
-Inhibits thyroid hormone synthesis

  • Does not destroy existing stores of thyroid hormone
  • Can take 3-12 weeks to achieve a euthyroid state
  • Safer than PTU
  • PO

Applications:

  • Graves’ disease
  • Adjunct to radiation therapy
  • Suppress thyroid synthesis in preparation for thyroidectomy
  • Avoid with pregnant women or breast feeding

Adverse Effects:

  • Agranulocytosis most serious and dangerous toxicity- more prone to getting sick
  • Dramatically reduces granuolcytes (type of WBC) needed to fight infection

Teach patient to Report sore throat, fever immediately!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Propylthiouracil (PTU)

A

Indicated for hyperthyroidism

MOA: Decreases the synthesis of thyroid hormones

-Can also cause agranulocytosis

Different from Tapazole in that :-Causes severe liver injury

  • Requires 2-3 doses per day
  • Safer in pregnancy and in breast milk
  • Blocks conversion of T4 to T3*

Indicated for:

  • Pregnant women in 1st trimester
  • breast-feeding women
  • Pts with thyroid storm
  • Pts intolerant of Tapazole
  • Can treat at a higher dose with PTU than tapazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta Blockers and Hypothyroidism

A

ο Beta Blockers also have a role in treatment of hyperthyroidism. To help decrease the HR while we are waiting for the drug to treat the actual condition to kick in. For some people they stay on it at a low dose

ο Suppress tachycardia and other symptoms of Graves’ disease

ο Benefits derive from beta-adrenergic blockade, not from reducing levels of T3 or T4

  • Also my be used in thyrotoxic crisis
  • Contraindicated in pts with asthma*

Beta Blockers- OLOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Propranolol(Inderal)

A

Nonselectivebetaadrenergicantagonist (Beta1 andbeta2)
o ↓ HR, ↓force of ventricular contraction and slow impulse conduction through the AV node, suppress secretion ofrenin (Beta1)
o Bronchoconstriction (Beta2)
o Inhibits glycogenolysis (Beta2)
♣ Breakdown of glycogen to glucose
♣ Most detrimental to diabetics
o Lipid soluble – easily crosses membranes
o Well absorbed
o Widely distributed
o Hepatic metabolism
o Excreted in the urine

Drug interactions:
-Calcium channel blockers- decreases the calcium from allowing contraction so withbetablockers it decreases the force of the heart as well. So together it will make it even harder for the muscle to contract.Typicallynot prescribed together because can cause HF

-Insulin- more vigilant about screening for hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metoprolol(Lopressor)

A

Cardioselective(Beta1 only)- only impactsbeta1receptors.

Pt with emphysema can take this

Therapeutic Uses:
o	HTN, heartfailure andMI
•	Hepatic metabolism
•	Renal excretion
•	Adverse Effects
o	Bradycardia, ↓ CO, AV block, rebound tachycardia with abrupt discontinuation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Local Anesthetics

A

Reversibly block all nerve impulses by disrupting permeability to sodium during action potential.

-Suppress impulse conduction along axons

  • Conduction blocked only in neurons near the site of administration
  • Sensations are blocked at different rates: pain first, followed by cold, warmth, touch, and deep pressure

-Not limited to sensory, may affect motor

Onset and duration affected by…
Ð	Molecular size
Ð	Lipid solubility
Ð	Degree of ionization
Ð	Regional blood flow- makes sure that the anesthetic gets good absorption

Frequently combined with epinephrine:

  • Vasoconstrictor decreases local blood flow and delays systemic absorption of the anesthetic
  • Decreases toxicity risk: less anesthetic used and slower absorption

Adverse Effects:
-Central Nervous System:
CNS agitation followed by depression

Cardiovascular system:

  • Heart cause suppression of excitability
  • Vessels causes vasodilation

Allergic reactions
-Varied

Labor and delivery
-Prolong labor by decreasing uterine contractility and maternal expulsion effort; can cause bradycardia and CNS depression in the neonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lidocaine

A
  • local anesthetic
  • Administered topically and by injection
  • Also used as an antidysrhythmic agent
  • Duration of action depends on strength
  • Addition of epinephrine
  • Risk of systemic toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lidocaine continued

A

Tetracaine is a topical lidocaine

  • Surface anesthesia
  • Pain, itching, soreness caused by infections, thermal burns, bruises, abrasions, plant poisonings, insect bites

Used in mucus membranes
-Risk for systemic toxicity

Systemic absorption determined by…

  • Amount applied
  • Skin condition
  • Skin temperature

Administration:

  • Smallest amount possible
  • Avoid application to large areas
  • Avoid application to broken skin
  • Avoid strenuous exercise
  • Avoid wrapping the site
  • Avoid heating the site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Injection

A
  • Resuscitation equipment should be immediately available
  • Maintain IV line for rapid treatment of toxicity
  • Aspirate to ensure not administering in a vessel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infiltration Anesthesia

A
  • Injected directly into area of surgery or manipulation
  • If combined with epinephrine
  • No end artery areas
  • No fingers, toes, noses, ears, or penis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nerve Block

A

-Achieved by injecting a local anesthetic into or near nerves that supply the surgical field, but at a site distant from the field itself
-Local Anesthetics
Injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intravenous Regional Anesthesia

A

-Used to anesthetize the extremities, but not the entire limb
-Anesthesia is obtained by injection into a distal vein of an arm or leg
-Tourniquet is applied to the limb to prevent anesthetic from entering the systemic –Local Anesthetics
Injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Epidural

A
  • Achieved by injecting a local anesthetic into the epidural space
  • Administration by bolus or by continuous infusion
  • Diffusion blocks conduction in nerve roots and in the spinal cord itself
  • Significant systemic absorption can occur

If given to pregnant mothers- Monitor for neonatal depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

General Anesthetics

A

Analgesia and Anesthesia

  • Analgesics are drugs that relieve pain without causing loss of consciousness.
  • Anesthetics are drugs that produce unconsciousness & insensitivity to painful stimuli
  • Produce unconsciousness and lack of responsiveness to all painful stimuli
  • Inhalation agents
  • Parenteral agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Balanced Anesthesia

A

Use of a combination of drugs to accomplish what we cannot achieve with an inhalation anesthetic alone

Compensates for lack of an ideal inhalation anesthetic

Allows for full general anesthesia at lower (safer) doses

General Anesthetics
Inhalation Agents
Minimal Alveolar Concentration
-The amount of anesthetic inspired air must contain to produce anesthesia
-Low MAC
-High MAC
Inhalation Agents
Uptake:
-MAC
-Pulmonary ventilation
-Solubility of anesthetic in blood
-Blood flow through the lungs

Distribution:

  • Determined by regional blood flow
  • Levels rise rapidly in brain, kidney, heart, and liver

Elimination

  • Via lungs
  • Anesthesia levels in the CNS decline more rapidly than in other tissues

Patients can waken from anesthesia before all anesthetic has left the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Adverse Effects of General Anesthesia

A
  • Respiratory depression
  • Cardiac depression- esp with someone who has cardiac issues

Increased risk with:

  • Chronic respiratory problems
  • Cardiac problems
  • Significant obesity

Malignant hyperthermia

  • Fatal reaction, genetic predisposition
  • Muscle rigidity, T up to 43 degrees C

Treatment: dantrolene sodium

Aspiration of gastric contents

  • Hepatotoxicity
  • Toxicity to operating room personnel
  • Headache, reduced alertness, spontaneous abortion
  • Ensure proper venting of gases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

General Anesthetics

Inhalation Agents

A
Volatile liquids “–fluranes”
EX: Isoflurane, enflurane,  desflurane, sevoflurane
-Rapid induction time
-Easy to adjust
-Rapid emergent time
-Causes hypotension, bradycardia

Gases: Nitrous oxide

  • “laughing gas”
  • Adjunct in balanced anesthesia
  • Can not produce surgical anesthesia alone
  • *Powerful analgesic, weak anesthetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adjuncts to in halation anesthesia ( pre-anesthesia/post anesthesia medications)

A

Pre-anesthetic meds: Benzodiazepines

  • Reduce anxiety and promote amnesia
  • Given to induce anesthesia or for conscious sedation
    ex: Midazolam (Versed)

Opioids
-Pain relief, cough suppressant

Preanesthetic Medications

  • Alpha 2-adrenergic agonists
  • Anticholinergic agents
  • Neuromuscular blocking agents

Postanesthetic Medications

  • Analgesics
  • Antiemetics
  • Muscarinic Agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intravenous anesthetics

A

Propofol (Diprivan)

  • Promotes release of GABA
  • General CNS depression
  • Induction and maintenance of GA

Sedation for mechanically ventilated patients, radiation therapy, diagnostic procedures

  • IV administration
  • Unconsciousness in less than 60 seconds
  • Duration is 3-5 minutes
  • Continuous infusion is needed for extended sedation

Adverse Effects

  • Respiratory depression/apnea
  • Hypotension
  • Risk of bacterial infection
  • Pain at the site of infusion

High abuse risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Opioids

A

MOA:

Opioid Receptors:
Mu and Kappa

Mu- opioids activate these
-Analgesia, respiratory depression, sedation, euphoria, physical dependence, and decreased GI motility

Kappa- opioids activate these
-Analgesia, sedations, and decreased GI motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Classifications of Opioids

A
  • Pure opioid
  • Agonist-antagonist opioid
  • Pure opioid antagonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Morphine

A

Strong Opioid Analgesic
Schedule II- moderate to high abuse potential

Therapeutic Use:

  • Analgesia
  • More effective against dull pain, than sharp intermittent
  • Post operative pain, cancer pain, labor and delivery pain
  • Can be used for MI, dyspnea with heart failure

MOA:
binds to mu receptors

Adverse Effects:

  • Respiratory depression
  • Constipation
  • Orthostatic hypotension
  • Urinary retention
  • Cough suppression
  • Biliary colic- gallbladder attack- right upper quad. Pain. Blocked bile duct of the galbladder
  • Emesis
  • Elevated intracranial pressure- make sure their blood pressure is normal
  • Euphoria/Dysphoria
  • Sedation
  • Miosis- more pupillary constriction
  • Birth defects
  • Neurotoxicity

Pharmacokinetics:
Routes of administration-
PO, IV, IM, SUB Q, Epidural, intrathecal- lower dose in the spine
-poor lipid solubility ( does not cross the blood brain barrier easily)

-inactivated by the liver and eliminated through the kidenys

TOlerance:

  • With MSO4 tolerance develops to analgesia, euphoria, sedation, and respiratory depression. Tolerance typically only occurs with long term use or giving large loading doses or taking it more frequent then prescribed.
  • Tolerance does not develop to constipation or miosis (pinpoint pupils)
  • Cross tolerance exists among other opioid agonists- tolerance of different drugs in the same drug class

Physical Dependence:

  • Abstinence syndrome when withdrawn
  • Intensity of withdrawal parallels the degree of physical dependence
  • DO NOT WITHDRAWAL ABRUPTLY
  • Strong Opioid Analgesics

Precautions:

  • Decreased respiratory reserve
  • Labor and delivery
  • Head injury- increase their ICP
  • Old and young- hold on to drugs for longer. Watch doses.
  • Liver impairment- will hold on to drug for longer.

Drug Interactions:
-other CNS depressants, anticholinergic drugs, hypotensive drugs, Mao inhibitors, opioids

Dosage guidelines:

  • fixed schedule
  • monitor vitals signs, especially respiratory rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Other Strong opioids

A

Fentanyl

  • Parenteral
  • Transdermal (Patch)
  • Transmucosal
  • Lozenge on a stick AKA Fentanyl pop- looks like candy. Beware of children
  • Intranasal

Methadone
Hydromorphone
Meperidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Moderate to strong Opioids

A
  • Produce less analgesia and respiratory depression
  • Produce sedation and euphoria
  • Lower abuse potential

Adverse Effects- works on the same receptors
-Similar to MSO4

Examples:

Codeine

  • 10% of the codeine dose is converted to MSO4 in the liver
  • Some people lack the gene to metabolize codeine so it is ineffective
  • Administered oral and parenterally
  • Either alone or in combination with non-opioid analgesics (ASA or acetaminophen)
  • Combination are effective because they relieve pain by different mechanisms
  • Schedule II
  • Combination products are Schedule III
  • Only administered orally
  • Effective cough suppressant
  • *Nursing mothers should be alert for signs of infant toxicity such as excessive sleepiness, breathing difficulties, poor feeding—seek medical attention

Oxycodone, Oxycontin

  • Oxycontin was reformulated in 2010 due to abuse
  • New formulation bears the imprint OP the old formulation bears the imprint OC
  • New formulation are harder to crush and if exposed to water or alcohol it turns into a gummy blob—cannot inject

Hydrocodone
-Combined with acetaminophen or ibuprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Agonist-antagonist Opioids

A

Pentazocaine

  • Agonist at kappa receptors
  • Antagonist at mu receptors
  • Limited respiratory depression

Adverse effects similar to MSO4
-Can precipitate withdrawal in persons physically dependent on pure opioids

Buprenorphine

  • Schedule III
  • Partial agonist at mu receptors
  • Antagonist at kappa
  • Analgesic effects similar to MSO4
  • Causes respiratory depression
  • Can precipitate withdrawal in persons physically dependent on pure opioids
  • Used in patients with severe chronic pain
  • Solution for injection, transdermal patches, sublingual tablets, sublingual film
  • Patches and solution for pain
  • Sublingual products are used for opioid addiction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Using Opioids

A
  • Pain assessment
  • Prior to administration and I hour after and DOCUMENT pain scale
  • VS- BP, HR, RR, o2 sat

What do we ask in a pain assessment????

  • 0-10 sale
  • Dosing
  • Individual variation

Dosing schedule:
-Fixed

Specific Pain Treated with Opioids

  • Postoperative
  • Obstetrical
  • Myocardial Infarction
  • Head Injury
  • Cancer Related Pain
  • Chronic Noncancer Pain

Physical Dependence/Abuse/Addiction

  • Physical Dependence
  • Abstinence syndrome occurs if the dependence producing drug is abruptly withdrawn

Abuse
-Drug use inconsistent with medical or social norms

Addiction

  • A disease process characterized by continued use of a psychoactive substance despite physical, psychological, or social harm
  • Patient fears about addiction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Patient Controlled Analgesia-

A

typically morphine or fentanyl

  • Self delivery of medication
  • There is a ceiling to the amount they can receive even if they keep pressing the button
  • Drug and dosages
  • Patient and family education
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Opioid Antagoinist

A

Naloxone (Narcan)

  • Blocks opioid actions
  • Will reverse effects of opioids if patient is receiving opioids
  • Analgesia, respiratory depression, sedation, euphoria
  • Can precipitate withdrawal in an opioid dependent patient
  • d/t lingering effects you may have to push it again even after you revived them the first time
  • Routes
  • IV, IM, subQ, Nasal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Methylnaltrexone (Relistor)

A

Used for opioid induced constipation
-Selective mu receptors

Route:
-subQ

Adverse Effects

  • Diarrhea
  • Abdominal pain
  • Flatulance
  • Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Non-opioid Centrally acting analgeiscs

A

Tramadol

  • Weak activity at mu receptors
  • Spinal inhibition of pain
  • Used for mild to moderate pain

Clonidine

  • Alpha 2 agonist
  • Blocks nerve pathways that transmit pain in the spinal cord
  • Used for severe cancer pain not relieved by opioids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Sedative-Hypnotic Drugs

A
  • Drugs that depress central nervous system (CNS) function
  • Primarily used to treat anxiety and insomnia
  • Antianxiety agents or anxiolytics
  • Distinction between antianxiety effects and hypnotic effects is often a matter of dosage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Sedative-hypnotics

A

Benzodiazepines

  • Diazepam (Valium)
  • Lorazepam (Ativan)* can give in IV form
  • Midazolam (Versed)* Can give in IV form
  • Alprazolam (Xanax)

Overview of pharmacologic effects:

  • Central nervous system
  • Reduce anxiety and promote sleep
  • Cardiovascular system
  • Oral vs. intravenous
  • Respiratory system
  • Weak respiratory depressants- be careful when mixing with opioids

Pharmacokinetics

  • Absorption and distribution
  • Readily cross the blood brain barrier

Metabolism

  • Metabolites are pharmacologically active
  • Time course of action
  • Differ from one another in onset and duration and tendency to accumulate

Therapeutic uses:

  • Anxiety
  • Insomnia
  • Seizure disorders
  • Muscle spasm
  • Alcohol withdrawal
  • Perioperative applications

Adverse effects:

  • CNS depression
  • Anterograde amnesia- unable to make new memories
  • Sleep driving
  • Paradoxical effects
  • Respiratory depression
  • Great Abuse potiential
  • Use in pregnancy and lactation

Other adverse effects
-hypotension

Drug interactions:
- other CNS depressants

Tolerance and physical dependence

  • Tolerance
  • With prolonged use, tolerance develops to some effects but not others
  • Physical dependence
  • Can cause physical dependence, but the incidence of substantial dependence is low
  • Acute toxicity

Oral overdose: Drowsiness, lethargy, and confusion

Intravenous toxicity: Life-threatening reactions, profound hypotension, respiratory arrest, and cardiac arrest

General treatment measures
Oral: Gastric lavage, activated charcoal, saline cathartic, and dialysis
-Acute toxicity
-Antidote (Romazicon)
-Competitive benzodiazepine receptor antagonist
-Reverses the sedative effects of benzodiazepines but may not reverse respiratory depression
-Approved for benzodiazepine overdose and for reversing the effects of benzodiazepines after general anesthesia
-Routes of administration
-Oral
-Parenteral (intramuscular and intravenous)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Management of insomnia

A

Treatment is highly dependent on the cause

Non-drug therapy 1st
-avoiding naps
-decrease caffeine
-exercise (no later that 7p)
-environmet
therapy with hypnotic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Drugs used for insomnia

A
  • Benzodiazepines
  • Benzodiazepine-like drugs: Zolpidem, zaleplon, and eszopiclone
  • Ramelteon
  • Antihistamines
36
Q

Benzodiazapine like-drugs

A

Zolpidem [Ambien]

  • Sedative-hypnotic
  • Most widely used hypnotic
  • Short-term management of insomnia
  • Long term use: No apparent tolerance or increase in adverse effects
  • Side effects: Daytime drowsiness and dizziness

Zaleplon [Sonata]

  • Short-term management of insomnia
  • Prolonged use does not appear to cause tolerance
  • Most common side effects: Headache, nausea, drowsiness, dizziness, myalgia, and abdominal pain

Eszopiclone [Lunesta]

  • For treatment of insomnia
  • No limitation on how long it can be used
  • Most common adverse effect: Bitter aftertaste
  • Other common side effects: Headache, somnolence, dizziness, and dry mouth
37
Q

Medications Affecting the Respiratory System

Inhalation Medications

A

Enhances therapeutic effects

  • Delivered directly to site of action
  • Minimizes systemic effects
  • Rapid relief of acute attacks

Delivery devices:

  • Metered-dose inhalers
  • Dry-powder inhalers
  • Nebulizers
38
Q

Metered-dose inhalers ( MDI)

A

inhaler has measured amount of drug with each puff. Need to shake it. Start to inhale with closed mouth on mouth piece.
Press and continue to inhale. Hold for 10 seconds. Take next dose if needed 1 to 2 minutes later.

MDI Spacers- you don’t lose med to atmospheric air. Good for kids that cant start inhaling before they press.

39
Q

Dry powdered Inhaler

A
  • many contain lactulose bulking agent helps raise medication- better facilitate med going in to the lungs
  • You will not loose as much as you do in MDIs
  • Pushing the lever back will get the med ready. Then pt will take good deep breath when ready. Pt. needs to be able to take a good breath to effectively get this medication.
  • teaching re: lactose intolerance/allergies
40
Q

Nebulizers

A
  • liquid that sits in a canister. Add O2 or air to vaporize it and make it a mist that the pt. will inhale.

Typically 8 to 10 L of air needed.

Can be connected to mouth piece or mask.

In acute attack you would want to use this. Works better getting drug into the lungs (quicker). But you do not get the whole concentration all at once.

41
Q

Classifications

A

Bronchodilators

  • Adrenergics
  • Anticholinergics
  • Xanthines

Antiinflammatories

  • Corticosteroids
  • Leukotriene modifiers
  • Mast Cell Stabilizers
Expectorants
Antitussives
Mucolytics
Nasal Decongestants
Antihistamines
42
Q

Bronchodilators

A

Beta 2-Adrenergic Agonist

-Stimulate the Beta 2 adrenergic receptors in smooth muscle of bronchi and bronchioles

  • Causes bronchodilation
  • Relieves bronchospasm
  • Suppresses histamine release in lung
  • Increases ciliary motility- gets the mucus up
43
Q

beta-2 adrenergic agonists

A

Short-acting beta 2 agonists (SABA)

-Taken PRN to relieve asthma attack- with exercise or you know you are going to be around a certain allergen.
EX: Albuterol (Proventil)

Long-acting beta 2 agonists (LABA)

  • For patients that experience frequent attacks
  • NOT PRN, taken on schedule
  • ALWAYS combined with glucocorticoid- if you have COPD you can take LABA by itself- no glucocorticoid needed.

If patient has asthma and does not take glucocorticoid they can have asthmatic cardiac arrest.
EX: Salmeterol (Serevent Diskus)

The beta 2 adrenergic agonists are selective, they are not absolute

  • Produce some activation of beta 1 receptors
  • Results in tachycardia
  • Monitor pulse before, during, after administration

CONTRAINDICATED: pts with angina, certain dysrhythmias

Other beta 2 effects: Tremor

44
Q

Anticholinergics

A

Muscarinic Antagonist

Which Results in bronchodilation

  • Approved only for COPD
  • Off label use in asthma

Inhalation meds:
Ipratropium (Atrovent)
Tiotropium (Spiriva)

Ipatropium (Atrovent)
-Used for bronchospasm

Can be used in combination drugs:
-Combivent (ipratropium/albuterol)
AVOID with pts with PEANUT ALLERGY

Tiotropium (Spiriva)
-Long-acting
Maintenance therapy of bronchospasm
Adverse Effect: Dry Mouth

Xanthines
Mechanism of action is unknown
-Bronchodilation
-Inhibits pulmonary edema 
-Increases ciliary action
-Decreases inflammation 

Theophylline, Caffeine

  • PO, Long-term treatment
  • Toxicity: Activated charcoal
  • N/V/D, insomnia, restlessness
  • Lethal heart rhythms

Aminophylline IV infusion
-Administer slowly, rapid administration can cause hypotension and death

45
Q

Anti-inflammatories

A
  • Long-term control (daily dosing)
  • Mainstay of asthma therapy

Corticosteroids (glucocorticoids):

First line treatment of asthma

  • Airway inflammation is suppressed
  • Decreases production of inflammatory mediators: leukotriene, histamine, prostaglandins
  • Decreases infiltration of inflammatory cells (eosinophils, leukocytes)
  • Decreases edema of airway
  • Decrease mucous production

Restores or increases effectiveness of Beta 2 receptors
-Increases responsiveness to Beta 2 agonists

Inhalation:

  • Fluticasone (Flovent)
  • Mometasone (Asmanex)

PO:
-Prednisone

IV
-Methylprednisolone (Solu Medrol)

Nebulizer:
-Budesonide (Pulmicort Respules)

Adverse Effects:

  • Oropharyngeal candidiasis
  • Dysphonia (hoarseness, difficulty speaking)

Nursing action: Rinse and gargle after each administration

Teach importance of using spacer

46
Q

Leukotriene Modifiers (antagonist)

A

Leukotriene’s (LT) are strong chemical mediators that cause bronchoconstriction, eosinophil infiltration, mucus production, airway edema

  • Prevent LT from acting on target tissues
  • Second line therapy, adjunct therapy

Singulair (montelukast) PO
- “I single out target cells”

Singulair indications:

  • Prophylaxis and maintenance of therapy in asthma; NOT rapid relief of acute episodes.
  • Prevent exercise-induced bronchospasm
  • 2 hours before start of exercise/lasts approx. 12 hours
  • Relief of allergic rhinitis

Adverse Effects

  • Neuropsychiatric effects:
  • Depression
  • Suicidal thinking and behavior
47
Q

Take home points re: respiratory mediations

A
  • Albuterol is initial drug of choice for acute bronchospasm
  • Aerosol products act directly on the airways = small doses=less side effects
  • Anticholinergics most useful for long-term management of COPD
  • Take inhaled corticosteroids on a regular schedule
48
Q

Expectorants (coughing)

A

Liquefy respiratory secretions and allow for easier removal
Action= increases respiratory tract flow

Guaifenesin (Mucinex)

49
Q

Mucolytics

A

Administered by inhalation or nebulized

  • Liquefy mucus
  • Productive cough
  • Effective within 1 minute

Acetylcysteine (Mucomyst) Inhalation

-PO form used for acetaminophen overdose

50
Q

Antipsychotic Agents

A
Used for broad spectrum of psychotic disorders:
¥	schizophrenia
¥	delusional disorders
¥	bipolar disorder
¥	depressive psychoses 
¥	drug-induced psychoses

Other use: suppress emesis

51
Q

Conventional antipsychotics~1st generation

A

Block receptors for dopamine in the CNS; cause extrapyramidal symptoms (EPS)- uncoordinated movements…

  • May be classified by low potency (Thorazine), medium potency, or high potency (Haldol). Haldol has greater risk of EPS than Thorazine.
  • Similar efficacy, difference in ability to produce side-effects (increased in high potency agents).
  • Extrapyramidal symptoms (neurological SE) common so conventional antipsychotics are also known as neuroleptics.
  • Block a variety of receptors: dopamine, acetylcholine, histamine, and norepinephrine

Current theory suggests that blockade of dopamine receptors suppresses symptoms of psychosis

Therapeutic Uses

  • Schizophrenia
  • Bipolar Disorder
  • Tourette’s Syndrome
  • Prevention of emesis: block dopamine receptors in the chemoreceptor trigger zone (CTZ) of the medulla
Examples of Conventional Antipsychotic Agents
-Chlorpromazine (Thorazine) ******for test
-Fluphenazine (Prolixin)
-Perphenazine (Trilafon)
-Thiothixene (Navane)
-Loxapine (Loxitane) 
-Haloperidol (Haldol) *****for test
Pimozide (Orap)
52
Q

Atypical antipsychotics~2nd generation

A

¥ Produce only moderate blockade of receptors for dopamine but has a much stronger blockade of receptors for serotonin
¥ Low risk of extrapyramidal symptoms
¥ Higher risk of diabetes, weight gain, dyslipidemia
¥ Now the first-choice antipsychotic agents

53
Q

Extrapyramidal symptoms

A

Movement disorders resulting from effects of antipsychotic drugs on the extrapyramidal motor system

Exact cause unclear; blockade of dopamine receptors is strongly suspected

Four types of EPS occur: acute dystonia, parkinsonism, akathisia, and tardive dyskinesia

54
Q

Acute Dystonia

A
  • Develops within the first few days of therapy; often within hours of the first dose
  • Severe spasm of the muscles of the tongue, face, neck, or back
  • Oculogyric crisis: involuntary upward deviation of the eyes
  • Opisthotonus: tetanic spasm of the back muscles causing the trunk to arch forward, while the head and lower limbs are thrust backward
  • Laryngeal dystonia can impair respiration
  • Requires rapid intervention
  • Drug will be given to try treat EPS while you continue to take the drug (treat the symptoms)
  • Initial treatment consists of anticholinergic medication, e.g. benztropine (Cogentin) or diphenhydramine (Benadryl) administered IM or IV; rapid symptom resolution
55
Q

Parkinsonism

A

-Antipsychotic-induced parkinsonism is characterized by bradykinesia, mask-like faces, drooling, tremor, rigidity, shuffling gait, and stooped posture
¥ Parkinson’s Disease (PD) and neuroleptic-induced parkinsonism share the same symptoms
¥ Eating difficulty
¥ Anticholinergic drugs are used to control symptoms
¥ Resolves spontaneously
Akathisia
¥ Characterized by pacing and squirming brought on by an uncontrollable need to be in motion
¥ Usually develops within the first 2 months of treatment
¥ Beta blockers, benzodiazepines, and anticholinergic drugs are used to control symptoms

56
Q

Tardive Dyskinesia (TD)-

A

***this is the only EPS symptom where meds wont reverse these side effects and will talk about withdrawing the drug and prescribing something else
¥ Most troubling of the EPS
¥ Develops in 15% to 20% to patients during long-term therapy
¥ Risk is related to duration of treatment and dosage
¥ Often symptoms are irreversible
¥ Choreoathetoid (twisting, writhing, worm-like) movements of the tongue and face
¥ Lip-smacking and “fly-catching” movements
¥ Over time, TD produces involuntary movements of the limbs, toes, fingers, and trunk
¥ Eating difficulties → malnutrition, weight loss
¥ Cause complex, not completely understood

57
Q

Treatment of Tardive Dyskinesia

A

¥ No reliable treatment
¥ Prevention is key; frequent assessment for early signs of TD
¥ Withdraw antipsychotic agent if possible; use smallest dose for shortest time required

58
Q

Neuroleptic Malignant Syndrome

A

Adverse effect of conventional antipsychotic agents

-“Lead pipe” rigidity, sudden high fever, sweating, autonomic instability (dysrhythmias, fluctuations in blood pressure) confusion, seizures, and death

Treatment is supportive measures and immediate withdrawal of antipsychotic agent

-Benzodiazepines, fluid support, Dantrolene, bromocriptine, antipyretics- something for a fever

59
Q

Other Adverse Effects of Conventional Antipsychotic Agents

A

Anticholinergic effects: dry mouth, blurred vision, constipation, tachycardia, urinary hesitancy, photophobia d/t drug (that has anticholinergic effect) on and the anticholinergic that the pt is on.

Can cause.
-Alpha1-adrenergic blocking: orthostatic hypotension

  • Histamine1 blocking: sedation- if given in one time does give at night time or break up in to small doses during the day.
  • Neuroendocrine effects: gynecomastia, menstrual irregularities
  • Seizures- lowers seizure threshold.
  • Sexual dysfunction
  • Agranulocytosis
  • Severe dysrhythmias
  • Severe sunburn with phenothiazines

Toxicity of Conventional
Antipsychotic Agents
-Large therapeutic index
-Lethal dose may be as high as 200 times the therapeutic dose

Drug interactions:

  • Anticholinergic drugs
  • CNS depressants- alcohol or antidepressants
  • Levodopa and Direct Dopamine Receptor Agonists- for patients with parkinsons- increases the amount of dopamine
60
Q

Chlorpromazine (Thorazine) Low potency

A

Therapeutic uses: Schizophrenia, schizoaffective disorder, manic phase of bipolar disorder, suppression of emesis and intractable hiccups
◦ PO, PR, IM, IV

Adverse effects: (Most common)

sedation, orthostatic hypotension, and anticholinergic effects (dry mouth, blurred vision, urinary retention, photophobia, constipation, tachycardia)
◦ Lowers seizure threshold

61
Q

◦ Lowers seizure threshold

} Haloperidol (Haldol) high potency

A

Therapeutic uses: Schizophrenia, acute psychosis, preferred drug for Tourettes Syndrome, intractable nausea/vomiting
◦ PO, IM, IV (not FDA approved)

Most common adverse effects: early extrapyramidal reactions (dystonia, parkinsonism, akathisia)
◦ Risk of TD same between high and low potency FGA’s
◦ Prolonged QT – get baseline and periodic ECG and K+ levels

62
Q

Atypical Antipsychotic Agents

Second Gen

A

These agents have similar efficacy as typical agents in controlling positive symptoms
-Greater efficacy in controlling negative symptoms

  • Fewer EPS and drugs are associated with a lower rate of relapse
  • May cause weight gain, diabetes, dyslipidemia (can lead to CAD)

MOA:

  • Block receptors for dopamine and serotonin
  • Some blocking of norepinephrine, histamine, and acetylcholine
  • Greater affinity for blocking of serotonin than dopamine, thus more acceptable side effect profile.
  • Also approved to treat bipolar disorder.

Adverse Effects of Atypical Antipsychotic Agents:
¥ Seizures
¥ Diabetes: in extreme cases, DKA; manage with oral antidiabetic agents or insulin
¥ Weight gain: due to blocking of histamine receptors; may lead to Type II diabetes
¥ Dyslipidemia: monitor lipids
¥ Sedation & Orthostasis
¥ Dementia/Elderly increased risk of death

63
Q

Clozapine (Clozaril)

A

Second Gen-

¥ Treats schizophrenia
¥ May cause agranulocytosis in 1% to 2% of patients
¥ Agranulocytosis typically occurs during the first 6 months of treatment
¥ Risk of death is about 1 in 5000 due to septicemia

Etiology of agranulocytosis is unknown
¥ Monitor WBC, neutrophils

64
Q

Maintenance Therapy

A

¥ Schizophrenia is a chronic disorder that usually requires prolonged treatment

-Following control of an acute episode, antipsychotic therapy should continue for at least 12 months; withdrawal before this time is associated with relapse

65
Q

Depot Medications for Schizophrenia

A

Benefits of depot:
Prevent relapse, maintain highest level of functioning
-Lower risk of EPS

Examples of depot:
¥ Haloperidol deconoate (Haldol)
¥ Risperidone microspheres (Risperdal consta)
¥ Fluphenazine deconoate (generic only)
¥ Olanzapine pamoate (Zyprexa relprevv)
¥ Aripiprazole (Abilify maintena)
¥ Paliperidone palmitate (Invega Sustenna, Invega Trinza)

Long acting injectable formulations

  • Drug levels remain stable
  • Lower risk of adverse effects, including TD
  • May help reduce relapse and improve adherence
  • Given every 2-4 weeks IM
66
Q

Mgmt of Schizophrenia

A
¥	Drug Selection
◦	Atypical generally first choice
◦	Depends on situation
¥	Dosing
◦	Highly individualized
◦	Initially daily divided doses then once daily at bedtime
◦	Bedtime dosing may help promote sleep
◦	May be higher early in therapy 

For long term therapy should use the lowest effective amount

Management of Schizophrenia
¥ Initial therapy
¥ Symptoms begin to resolve within 1-2 days
¥ Significant improvement is seen in 1-2 weeks

Maintenance therapy
¥ Reduce recurrence of acute episodes and maintain high level of functioning

Adjunctive therapy

Nursing Implications

  • Patients need a thorough mental status exam and a physical exam.
  • Determine VS, labs (CBC, lytes, evals of hepatic, renal and CV function).
  • Watch for contraindications
  • Promote adherence
  • Minimize adverse effects and interactions
67
Q

Antidepressants

A

Psychotherapy AND pharmacotherapy Best results

  • Monoamine hypothesis of depression
  • A functional insufficiency of monoamine neurotransmitters (norepinephrine, serotonin or dopamine)

Treatment Modalities for Depression

  • Pharmacotherapy
  • Depression-specific psychotherapy
  • Somatic Therapies
  • Electroconvulsive therapy
  • Transcranial magnetic stimulation

Relief of depression takes weeks to months; psychotherapy is a key element

Important to assess for suicide risk*

Drug Selection/Managing Treatment

  • Initial therapy
  • 4-8 weeks to assess efficacy
  • Start low gradually increase

If initial therapy is not effective
◦ Increase the dosage
◦ Switch to another drug in the same class
◦ Switch to another drug in a different class
◦ Add a second drug

Encourage patients to continue therapy even if symptom free

Suicide Risk with Antidepressants

  • Antidepressants can increase the risk of suicide
  • Higher risk among children, adolescents, and young adults <25
  • Box Warning on all antidepressants
  • Observe closely for suicidality, worsening mood, or changes in behavior
  • Observe closely during initial therapy and with changes in drug or drug dosages
  • Antidepressants can be used to commit suicide
  • Prescribe the smallest number of doses
  • Inpatient dosing should be directly observed to ensure ingestion (no “cheeking”)
68
Q

Antidepressants

A

Selective Serotonin Reuptake Inhibitors (SSRIs) ~First line treatment~

Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Tricyclic Antidepressants (TCA)

Monoamine oxidase inhibitors (MAOI)

Atypical Antidepressants

69
Q

SSRI

A

Most commonly prescribed group of antidepressants

  • Fluoxetine (Prozac, Sarafem) is prototype agent
  • Fewer side effects than TCA & MAOI

Death by overdose extremely rare

Mechanism of Action:

  • Blocks re-uptake of serotonin
  • Does not block uptake of dopamine or NE
70
Q

Fluoxetine (Prozac)

A

Therapeutic Uses:

  • Major depression
  • Bipolar
  • Obsessive compulsive disorder
  • Panic disorder
  • Bulimia
  • PMDD

Pharmacokinetics:

  • Well absorbed orally even with food
  • Prolonged half life
  • 4 weeks to produce steady state effects

Adverse Effects:-most common

  • Sexual dysfunction
  • Nausea
  • Headache
  • CNS Stimulation (nervousness, anxiety, insomnia)
  • Weight gain
  • Increased bleeding risk
  • Serotonin syndrome
  • Withdrawal syndrome
  • Dizziness, HA, nausea, sensory disturbances, tremor, anxiety and dysphoria

Taper the dose slowly

  • Selective Serotonin Reuptake Inhibitors (SSRI) Drug :Interactions
  • MAOIs
  • Tricyclic antidepressants
  • Antiplatelets and anticoagulants
71
Q

Tricyclic Antidepressants (TCA)

A

Amitriptyline (Elavil): prototype agent

Tricyclic anti-depressants (TCAs) – named for three ring chemical structure

Mechanism of action:

Block neuronal reuptake of two monoamine transmitters – norepinephrine and serotonin
-Also blocks receptors for histamine and acetylcholine

-Although fewer SE and less dangerous than MAO inhibitors there still are significant SE.

Therapeutic Uses

  • Depression
  • Bipolar disorder
  • Fibromyalgia
  • Neuropathic pain
  • Insomnia
  • ADHD
  • OCD
  • Migraine HA prophylaxis

Adverse Effects

  • Anticholinergic effects
  • Block muscarinic cholinergic receptors
  • Dry mouth, blurred vision, photophobia, constipation, urinary hesitancy and tachycardia
  • Orthostatic hypotension
  • Block alpha1-adrenergic receptors on blood vessels
  • Cardiac toxicity
  • Seizures
  • Sedation
  • Hypomania
  • Suicide risk
Drug Interactions:
¥	Monoamine Oxidase Inhibitors
-Severe hypertension
-Anticholinergic agents
-CNS depressants
-Toxicity/Overdose

Overdose
Overdose is life threatening
-Related to anticholinergic blockade and cardiotoxicity
-Treatment is gastric lavage and activated charcoal
-Treat dysrhythmias

72
Q

Monoamine Oxidase (MAO) Inhibitors

A

2nd or 3rd choice antidepressants

-High risk of triggering hypertensive crisis

Used for atypical depression

MAO – an enzyme found in the liver; converts monoamine neurotransmitters (NE, serotonin, and dopamine) into inactive products

By inhibiting MAO, drug increases NE and serotonin, intensifies transmission at receptor

  • Inhibition is irreversible
  • Must wait for synthesis of new MAO molecules, may take two weeks

Therapeutic Uses
Reserved for patients who have not responded to TCAs, SSRIs and other safer drugs
-Atypical depression

Adverse Effects

  • CNS stimulation
  • Orthostatic hypotension
  • Hypertensive Crisis from dietary Tyramine
  • Rigid dietary restrictions (Tyramine) – all cheeses, figs, bananas, caffeine, liver, chianti

Multiple Drug Interactions

  • Indirect-acting Sympathomimetic Drugs
  • TCAs
  • SSRIs
  • Antihypertensive drugs
  • Meperidine
73
Q

Bupropion (Wellbutrin)

A

Atypical Anti-depressant

  • Similar in structure to amphetamines
  • Effects begin in 1-3 weeks
  • Mechanism unclear
  • Does not decrease sexual interest; may increase sexual desire
  • Zyban formulation: used to help quit smoking

Adverse Effects:
-Seizures – when dosage is too high

Common: agitation, H/A, dry mouth, constipation, weight loss

Drug Interactions
- MAO’s increase risk of Bupropion (Wellbutrin) toxicity – discontinue two weeks before starting bupropion

Nursing Implications
-BEFORE administration
-Obtain complete list of medications
-Obtain baseline vital signs, heart rhythm
-Assess mental status and thoughts of suicide
TCAs: smoking = decreased effectiveness

AFTER administration

  • Vital signs, heart rhythm
  • Check mental status & suicidal thoughts
  • Orthostatic hypotension precautions
74
Q

Patient education and Antidepressants

A

¥ Take exactly as prescribed
¥ Symptoms will persist up to 8 weeks
¥ Keep follow-up appointments
¥ Take medication even if feeling well

Missed dose: take as soon as possible unless it is almost time for next dose then just take next dose do not double up

May need to be gradually discontinued

  • Avoid driving, operating machinery until adjusted to medication and side effects known
  • Avoid alcohol (increases drowsiness)
  • If patient is transitioning off antidepressant to an MAOI to wait 14 days to start new drug
  • Can cause serotonin syndrome
  • Wear a medical alert bracelet
75
Q

Drugs for Bipolar

A

what is Bipolar: Severe biologic illness-Recurrent fluctuations in moods; Alternate between elevated mood and depressed

Treatments:
Mood stabilizers
¥ Relieve symptoms during manic and depressive episodes
¥ Prevent recurrence
¥ Do not worsen symptoms or accelerate cycling

Antipsychotics
¥ Control symptoms during severe manic episodes
¥ Used in combination with a mood stabilizer

Antidepressants
¥ Combined with a mood stabilizer to prevent mania or hypomania

Benzodiazepines- during manic acute episodes
¥ Used for sedation

Drug Selection

  • Acute Therapy: Manic episodes
  • Lithium (drug of choice) or Valproate
  • Second-generation antipsychotic (atypical)
  • +/- benzodiazepine

Depressive episodes Antipsychotics

  • Mood stabilizer
  • Second-generation antipsychotic
  • +/- antidepressant

Long-term Preventative Therapy

  • Purpose prevent recurrence
  • Mood stabilizers—choice based on what worked during acute phase
  • Adherence is key
76
Q

Mood Stablizers

A

Lithium, Valproic acid, Carbamazepine

Lithium- works the best, first drug of choice
Low therapeutic index

Therapeutic Uses

  • BPD
  • Drug of choice for controlling acute manic episode and long term prophylaxis against recurrence
77
Q

Lithium

A

Mechanism of action unknown

Pharmacokinetics

  • PO
  • Well absorbed evenly distributed
  • Short half life – requires divided daily doses
  • Excreted in kidneys -caution in renal impairment
  • Renal excretion of lithium is affected by blood levels of sodium
  • ↓sodium level → ↓lithium excretion

The kidneys process lithium and sodium the same way so when sodium is low it will hold on to lithium

  • When the kidneys sense sodium levels are inadequate, they retain lithium in an attempt to compensate
  • Dehydration lithium toxicity
  • Plasma lithium levels
  • Maintenance levels 0.4-1.0 mEq/L

Draw levels in the am 12 hours after the evening dose trough 30 minutes before next dose

  • Measure every 2-3 days at beginning of treatment
  • During maintenance draw levels every 3-6 months
  • Lithium levels above 1.5 mEq/L can cause significant toxicity

Effects with therapeutic Lithium levels:

  • Gastrointestinal effects- N/V, bloating
  • Fine hand tremors- can inhibit signs of daily living- give low dose of beta blocker and see if it balances out
  • Polyuria- inhibits ADH
  • Thirst
  • Renal toxicity
  • Goiter and hypothyroidism
  • Teratogenesis- increases lithium in the breast feeding child

Effects with excessive Lithium Levels

  • Persistent GI upset
  • Confusion
  • Hyperirritability of muscles
  • ECG changes
  • Sedation
  • Blurred vision
  • Seizures
  • High output of dilute urine
  • Ultimately death

Drug interactions

  • Diuretics
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) increase lithium levels by 60%
  • Anticholinergic drugs

Preparations, dosage, and administration
- Lithium carbonate (tablets)
- Lithium citrate (syrup)
Dosage is highly individualized

78
Q

Valproic Acid (Depakote)- anticonvulsant

A
Drug of choice for many patients
¥	Anti-seizure medication
¥	Increases level of GABA
¥	Control symptoms in acute manic episodes and prophylaxis against recurrent episodes of mania and depression
¥	Works faster 
¥	Higher therapeutic index than lithium
¥	Adverse effects
¥	Thrombocytopenia
¥	Pancreatitis
¥	Liver failure
¥	Teratogenic
¥	GI – use enteric coated formulation
¥	Weight gain
79
Q

Antianxiety Medications

A

Most commonly used drug classes:

  • Benzodiazepines – used for general anxiety disorder & panic disorder
  • SSRIs effective in all anxiety disorders

Psychotherapy along with drug therapy is a key component of successful management
-Unrealistic or excessive anxiety about >1 event or activity lasting 6 months or more

Treatment  ¥	1st line: SSRI, SNRI, buspirone ¥	2nd line: benzodiazepines
80
Q

Generalized Anxiety Disorder

-Antidepressants

A
For long-term management, not acute episodes
¥	Can take several weeks to take effect
¥	SNRI’s and SSRI’s
¥	Venlafaxine (Effexor ER)
¥	Duloxetine (Cymbalta)
¥	Paroxetine (Paxil)
¥	Escitalopram (Lexapro)
81
Q

Buspirone (BuSpar)

A

Anxiolytic, not structurally related to benzos

  • Not a CNS depressant
  • Similar anxiolytic efficacy compared to benzos—some question about the evidence

Effects develop slowly

  • Not for prn dosing
  • Start therapy 2-4 weeks prior to initiating benzodiazepine taper
  • No abuse potential
  • Well absorbed

Administration with food delays absorption but enhances bioavailability

Adverse Effects

  • Nervousness and excitement
  • Dizziness
  • Nausea
  • Headache

Drug and Food Interactions

  • Erythromycin- enhance concentration
  • Ketoconazole- enhance concentration
  • Grapefruit juice- enhance concentration

Has been used for up to one year without evidence of tolerance

82
Q

Panic Disorder treatments

A

¥ Peak intensity within 10 minutes, can last up to 30 minutes
¥ Patients often think symptoms to be a heart attack
¥ Agoraphobia occurs in 50% of the patients with Panic Disorder

Treatment
-Cognitive behavioral therapy, exercise, avoid sympathomimetics & caffeine

  • Antidepressants: SSRIs, SNRIs, TCAs and MAOIs
  • Benzodiazepines: alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan)
83
Q

Obsessive-Compulsive Disorder (OCD)

A

Obsession: Recurrent persistent thought impulse or mental image

Compulsion:Ritualized behavior in response to the obsession

Treatment

Behavioral therapy: important

  • SSRIs
  • TCA: clomipramine
84
Q

Social Anxiety Disorder (SAD)

A

Intense irrational fear of situations in which one may be scrutinized by others

Treatment ~ individualize

  • Nondrug Therapy/Psychotherapy
  • SSRIs
  • Benzodiazepines
  • Propanolol (Inderal): non-selective beta adrenergic antagonist
  • Performance anxiety
  • Small dosage taken 1-2 hours before performance

WHY BETA BLOCKER?

85
Q

Post-traumatic Stress Disorder (PTSD)

A

Develops following a traumatic event

  • Fear, helplessness or horror
  • Re-experiencing the event
  • Avoidance of reminders
  • Persistent state of hyperarrousal

Treatment

  • Psychotherapy
  • Drug Therapy
  • SSRI’s